Documente Academic
Documente Profesional
Documente Cultură
GUILLAIN-BARR
B Y:
SYNDROME
Y O E L R AY S O R G I A S E M B I R I N G M E L I A L A
1
INTRODUCTION
2
INTRODUCTION
3
OBJECTIVE
4
CASE
5
CASE
8
PHYSICAL EXAMINATION
Generalized state
Sensorium : Compos Mentis
Temperature : 36,8C
Body Weight (BW) : 15 kg
Body Height (BH) : 106 cm
BW/A: 75% | BH/A: 92% | BH/BW: 83%
Anemia (-), Cyanotic (-), Dyspnea (-), Edema (-), Icteric
(-)
9
PHYSICAL EXAMINATION
Localized Status
Head:
Eye: Light reflex(+/+), isochoric pupil, anemic
inferior palpebral conjunctiva (-/-)
Ear, Nose, Mouth: any abnormality was not found.
Neck: Enlargement of lymph node (-)
Chest:
Fusiform symmetrical, retraction (-)
HR: 104 bpm, regular, murmur(-)
RR: 26 brpm, regular, rhonchi (-/-)
10
PHYSICAL EXAMINATION
Abdomen:
Flexible, Peristaltic (+) Normal.
Enlargement of liver and spleen (-)
Extremity
Pulse: 104 bpm, regular, p/v strong, CRT <3
Lower limb weakness(+/+), KPR (-/-), Achilles
Reflex
(-/-)
11
LABORATORY EXAMINATION
Hb/Eri/Leu/Ht/T : 11,4/4,54/6.990/36/380.000
MCV/MCH/MCHC : 80/25,1/31,3
N/L/M/E/B : 71,9/24,7/3,4/0/0
Ca/Na/K/Cl : ,4/141/3,7/106
Ad-random glucose blood : 147mg/dL
BUN/Ur/Cr : 8/17/0,43
12
DIAGNOSIS
Differential Diagnosis
Guillain-Barr syndrome
Transverse myelitis
Polymyolitis
Diagnosis
Dd/ - Guillain-Barr syndrome
- Transverse myelitis
13
MANAGEMENT
Therapy
Inj. Methylprednisolone 375 mg/ 24 hours/IV
Inj. Ranitidine 15 mg/12 hours/IV
Investigation Plan
Vertebrae X-Ray
Vertebrae MRI
14
FOLLOW UP 27TH MAY 2017
15
FOLLOW UP 27TH MAY 2017
16
FOLLOW UP 28TH MAY 2017
17
FOLLOW UP 29TH MAY 2017
20
FOLLOW UP 1ST JUNE 2017
24
DISCUSSION
25
DISCUSSION
26
DISCUSSION
27
DISCUSSION
29
DISCUSSION
30
CONCLUSION
31
CONCLUSION
32
THANK YOU
33